Genetic Gamble” is an amazing article by Gina Kolata at the New York Times and brings new hope for people with cancer. Dr. Lukas Wartman, a young and talented doctor was diagnosed with the very cancer he was studying – adult acute lymphoblastic leukemia. No known treatment could save him.

According to the article, his colleagues at Washington University St. Louis investigated his complete genetic makeup using cancer genome sequencing and found a gene causing his cancer growth – FLT3 . FLT3 was active in his leukemia cells. Its normal role is to make cells grow and proliferate.

They found a kidney cancer drug called Sutent (sunitinib) that inhibits FLT that could shut down the malfunctioning gene.

He started taking the kidney cancer drug and he is now in remission after being given a certain death sentence.

More here at NY Times.

5 thoughts on “Dr. Lukas Wartman FLT3 Gene Causing His Adult Acute Lymphoblastic Leukemia is Stopped with Sutent – Reports NY Times”

  1. VIC says:

    estoy a la espera de la conectividad con ustedes para enviar la informacion,
    para dar tratamiento de Lukas. por Terapia Genica.
    Solo faltan los nombres y apellidos de Lukas.

  2. VIC says:

    en youtube he puesto un video que puede ayudar a comprender las bases de mi
    Terapia.
    https://www.youtube.com/watch?v=5n0bHMFdESY
    Están identificados los componentes de la Leukemia linfocitica. por tanto espero vuestra
    respuesta. EL TIEMPO ES ORO para LUKAS

  3. Estimado Sr. Vic:
    Entendemos su situación y quisiera sugerir que ponerse en contacto con su médico para que él tiene / que ponerse en contacto con el doctor Timothy Ley, Director Asociado del Genoma de la Universidad de Washington Institute (https://www.wustl.edu/).

    La información el Dr. Ley se pueden encontrar en esta dirección web: https://genome.wustl.edu/people/ley_timothy. También se proporciona un enlace a la noticia original para el que usted puede ofrecer a su médico de referencia. https://www.nytimes.com/2012/07/08/health/in-gene-sequencing-treatment-for-leukemia-glimpses-of-the-future.html?_r=1&pagewanted=all

    Todo lo mejor

       – El equipo de Genes Mundial

    Translation:

    Dear Mr. Vic:
    We understand your situation and would like to suggest you contact your physician to have he/she get in touch with Dr. Timothy Ley, Associate Director of the Washington University’s Genome Institute (https://www.wustl.edu/).

    Dr. Ley’s information can be found at this web-site address: https://genome.wustl.edu/people/ley_timothy. Also provided is a link to the original news article for which you may provide your physician as a reference. https://www.nytimes.com/2012/07/08/health/in-gene-sequencing-treatment-for-leukemia-glimpses-of-the-future.html?_r=1&pagewanted=all

    All our best

    – The Global Genes Team

    Editor’s Note:
    The views and opinions expressed on this blog do not necessarily reflect the thoughts or opinions of Global Genes | R.A.R.E. Project.  The information in this blog was shared and not initiated; thus, any quote or product claim should be verified with the writer.

    Nota del Editor:
    Las opiniones expresadas en este blog no necesariamente reflejan los pensamientos u opiniones de los genes a nivel global | RARE Proyecto. La información en este blog fue compartida y no se inició, por lo que cualquier cita o reclamación del producto debe ser verificada con el escritor.

  4. juan carlos cevallos says:

    me podrian guiar con el tratamiento de ñla leusemia mi hermano de 16 años tiene leusemia aguda he leido en internet sobre la graviola y la guanabana que tan cierto es q tiene propiedades 10000 veces mejor que la quimio terapia su punto de vista por favor

    I could guide treatment of ñthe Leusemia my 16 year old brother has acute Leusemia have read on the internet about graviola soursop and how true is q has properties 10000 times better than the chemo therapy your view please

  5. It’s awesome in support of me to have a web site, which is good designed for my knowledge.

    thanks admin

Comments are closed.